Related Experiment Videos
[Immunological rejection in rat embryonic brain tissue transplantation: experimental study]
1Department of Neurosurgery, Xinqiao Hospital, 3rd Military Medical College, Chongqing.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|January 1, 1997
Summary
Brain transplantation in rats showed that immunosuppression is crucial. Without cyclosporin A, immune cells attacked the graft, indicating the central nervous system is not immunologically privileged.
Area of Science:
- Neuroscience
- Immunology
- Transplantation Biology
Context:
- The central nervous system (CNS) was historically considered an immunologically privileged site, potentially allowing for successful allogeneic transplantation without immunosuppression.
- Investigating immune responses to brain grafts is essential for understanding transplantation barriers and developing therapeutic strategies.
Purpose:
- To evaluate the survival and immune response of embryonic neocortical allografts in adult rat recipients.
- To determine the role of immunosuppression (cyclosporin A) in mitigating graft rejection.
Summary:
- Embryonic rat/mouse neocortex was grafted into adult rats, with one group receiving cyclosporin A.
- Immunocytochemistry revealed increased T-cells (helper-inducer and cytotoxic-suppressor) and major histocompatibility complex (MHC) class II-expressing cells in non-immunosuppressed grafts.
- Graft survival was significantly higher in the cyclosporin A-treated group, demonstrating an immune response against the allografts.
Impact:
- This study challenges the concept of CNS immunological privilege, confirming that brain allografts are subject to immune rejection.
- Findings underscore the necessity of immunosuppressive therapy for successful brain transplantation and offer insights into the cellular mechanisms of CNS immune responses.